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We retrieved 39,224 treatment requests from 13,780 cancer patients from October 2011 to February 2017. 59.6% of the patients were women. Table 1 shows the demographics of these patients by gender.
All Patients

RESULTS
Anonymized demographic and clinical data were retrieved from Auditron© Evidências -Kantar Health a proprietary database of administrative claims.
Auditron© has information provided by over 50 health insurance companies (HIC) including information of 41 health plans from all over the country, 575 different oncology clinics/ hospitals and 1,950 oncologists and hematologists.
From October 2011 to February 2017 we collected data on the type of cancer (ICD), demographic characteristics, stage and TNM status from all patients registered in Auditron©.
Descriptive analyses were performed for the main characteristics of the patients and tumors.
Among the most common tumor types (breast and prostate cancer), we retrieved the drugs that were prescribed by class/intention.
METHODS
Scientific progress in oncology led to development of new tools for diagnosis and novel therapies resulting in survival gain for several neoplasms and increased costs related to disease management. Therefore, increased cancer management-related cost has been a new concern for patients, health care providers, and society (1, 2).
Treatment pattern studies and real-world evidence have a larger external validity when compared with randomized clinical trials. They are also of great importance to understand the real treatment scenario of certain diseases (3, 4).
There is an unmet need when it comes to real world studies in Brazil, especially in the perspective of the private health care system. Therefore, the aim of this study is to present the profile of cancer patients treated in the private setting in Brazil. Table 2 shows the percentages of T, N and M status for all patients with available information in the Auditron© database.
x: not identified; IS: in situ The rates of T, N and M status for patients with breast cancer with available information in the Auditron© database are shown in Table 4 .
There were 11,463 treatment requests for breast cancer, which included 21,867 drugs. Table  5 shows the distribution of each class of drug prescribed.
The majority of patients from Auditron© database had a diagnosis of breast cancer (n=4,155), representing 33.2% of the total. Table 3 shows the demographic characteristics of these patients. The second most common cancer on Auditron© database was prostate cancer, with 1,494 patients, representing 10.8% of the total. Their characteristics are depicted on Table 6 . Figure 4 shows the distribution of prostate cancer stagings among patients.
Breast Cancer
Prostate Cancer
There were 4,173 prescriptions, including 5,076 drugs retrieved for patients with prostate cancer. Table 8 shows the distribution of each class of drug prescribed. Most of the patients in Auditron were women, in stage IV of the disease and from South and Southeast regions, which comprise the richest states in the country, and therefore with the highest rates of patients from the private healthcare system.
The most prevalent cancers in the database were breast and prostate cancer, corroborating data from the Brazilian National Cancer Institute (INCA).
CONCLUSIONS
Chemotherapy is the main treatment for breast cancer, followed by supportive drugs. Hormone therapy is widely used for prostate cancer, with a small proportion of biologics prescribed. 24.5% Figure 3 shows the stage distribution among patients diagnosed with breast cancer.
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